Cost-Effectiveness Of Using Clinical Risk Factors With And Without DXA For Osteoporosis Screening In Postmenopausal Women
Predicting a woman's risk of osteoporotic fractures should be based on both clinical risk factors and measurement of bone density. Because measurement of bone density is quite expensive, there has been increasing interest to estimate fracture risk by clinical risk factors. Women at increased risk may be selected by clinical risk factors with or without measurement of bone density. The study "Cost-effectiveness of using clinical risk factors with and without DXA for osteoporosis screening in postmenopausal women", recently published in Value in Health, examines the usefulness of clinical risk factors. The study was co-authored by Dr. Afschin Gandjour.
Amgen Issues Statement On Outcomes Of Advisory Committee For Reproductive Health Drugs ACRHD Meeting
Amgen Inc. (Nasdaq: AMGN) issued the following statement on the outcome of today's meeting with the U.S. Food and Drug Administration (FDA) Advisory Committee for Reproductive Health Drugs (ACRHD) to review the potential use of Prolia(TM) (denosumab) for the prevention and treatment of postmenopausal osteoporosis and the prevention and treatment of bone loss in patients undergoing hormone ablation for either prostate cancer or breast cancer. After reviewing safety and efficacy data from 30 clinical studies involving more than 12, 000 patients, the Committee recommended approval of Prolia for the treatment of postmenopausal osteoporosis and for the treatment of bone loss in patients undergoing hormone ablation for prostate cancer.
Osteoporosis, a bone condition affecting, according to the International Osteoporosis Foundation, over seventy-five million people in the U.S., Europe, and Japan, has been dominating headlines. Recently, the Canadian Medical Association Journal published a study stating that older people who break a hip have nearly a 25% chance of dying in the next five years, with a 16% five-year death rate for those who suffer a spinal fracture. Nearly eight thousand people aged fifty and older from all parts of Canada participated in the study, explained author George Ioannidis, a health research methodologist at McMaster University in Hamilton, Ontario, who found that a hip fracture increases the risk of death 3.
It is Tammy Haut-Donahue 's quest to rid the world of osteoarthritis, which afflicts 20 million Americans. Some suffer from injury; others from the wear and tear of age. The condition results from the degeneration of the cartilage in joints, the most troublesome being the knee. When cartilage is worn away, a painful rubbing of bone on bone occurs. Haut-Donahue, a mechanical engineer at Michigan Technological University, believes the cure for osteoarthritis will begin with the meniscus, a little-understood buffer between the two major leg bones the femur and the tibia that meet in the knee. She endeavors to unravel its mysteries. Artificial replacements for damaged tissue are not effective.
If you are 50 or older and you break your hip, you have a one in four chance of dying within five years. Break your back, and you have a one in six chance of dying that soon, says a McMaster University study. The research, published in the online edition of the Canadian Medical Association Journal (CMAJ), has found that approximately 25 per cent of men and women who develop hip fractures and 16 per cent of people who develop spine factures will die over a five-year period. The national study was led by George Ioannidis, a health research methodologist in the Michael G. DeGroote School of Medicine, in collaboration with scientists from the schools of medicine and nursing at McMaster, as well as several universities across Canada.
The American College of Surgeons is deeply disturbed over the uninformed public comments President Obama continues to make about the high-quality care provided by surgeons in the United States. When the President makes statements that are incorrect or not based in fact, we think he does a disservice to the American people at a time when they want clear, understandable facts about health care reform. We want to set the record straight. -- Yesterday during a town hall meeting, President Obama got his facts completely wrong. He stated that a surgeon gets paid $50, 000 for a leg amputation when, in fact, Medicare pays a surgeon between $740 and $1, 140 for a leg amputation.